Product description

The present Competitive Intelligence Report about Anti-Obesity Peptides and Biologics used to treat obesity and metabolic syndrome provides a competitor evaluation in the field of R&D projects with anti-obesity peptides and biologics as of February 2012. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. The database also contains information about discontinued projects. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
The report includes a compilation of current active projects in research and development of anti-obesity peptides and biologics such as proteins, antibodies, vaccines, cells, and RNA. In addition, the report lists company-specific R&D pipelines of anti-obesity peptides and biologics. Competitor projects are listed in a tabular format providing information on:
-Drug Codes,
-Target / Mechanism of Action,
-Class of Compound,
-Company,
-Product Category,
-Indication,
-R&D Stage and
-additional comments with a hyperlink leading to the source of information. 

About Competitor Analysis Series:

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced. 

Table Of Contents

Competitor Analysis: Anti-Obesity Peptides and Biologics
Table of Contents

--Obesity Peptides
-Anti-Obesity Biologics
-Corporate RandD Pipelines of Anti-Obesity Peptides and Biologics
-About La Merie

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Japanese Encephalitis - Pipeline Review, H2 2014

Japanese Encephalitis - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Japanese Encephalitis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Japanese Encephalitis - Pipeline Review, H2 2014’, provides an overview of the Japanese Encephalitis’s therapeutic ...

Cedar Pollen Allergy - Pipeline Review, H2 2014

Cedar Pollen Allergy - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Cedar Pollen Allergy - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Cedar Pollen Allergy - Pipeline Review, H2 2014’, provides an overview of the Cedar Pollen Allergy’s therapeutic ...

Plague - Pipeline Review, H2 2014

Plague - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Plague - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Plague - Pipeline Review, H2 2014’, provides an overview of the Plague’s therapeutic pipeline. This report provides comprehensive ...

Anthrax - Pipeline Review, H1 2015

January 2015 $ 2 000

Dengue - Pipeline Review, H1 2015

January 2015 $ 2 000

Download Unlimited Documents from Trusted Public Sources

Global Vaccine Industry

  • March 2015
    64 pages
  • Vaccine  

    Occupational He...  

  • United States  

View report >

Vaccine Industry in Europe

  • March 2015
    3 pages
  • Vaccine  

    Autoimmune Dise...  

  • Europe  

View report >

Global Biopharmaceutical Market Trends

  • March 2015
    3 pages
  • Monoclonal Anti...  

    Vaccine  

    Recombinant Pro...  

  • Europe  

    North America  

    World  

View report >

Related Market Segments :

R&D
Obesity

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.